Geneuro

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
watoo75
Newbie
Posts: 6
Joined: Sun Jun 03, 2007 2:00 pm
Location: PARIS
Contact:

Geneuro

Post by watoo75 »


Biotech Showcase™: GeNeuro homes in on ancestral viral genes to treat autoimmune diseases

Focusing on an idea that many autoimmune diseases are caused by proteins from viral genes that are now embedded in human DNA, Swiss biotech GeNeuro is using the approach to tackle diseases such as multiple sclerosis and type 1 diabetes. Indeed, 8% of the human genome comes from genes left there by infections that affected our ancestors. Speaking at the 2018 Biotech Showcase, GeNeuro co-founder and CEO Jesús Martin-Garcia explained to Scrip how the company is advancing therapeutic candidates designed to neutralize the causal factors encoded by human endogenous retroviruses that lead to autoimmune diseases. The company’s lead programs focusing multiple sclerosis, and partnered with Servier, and type 1 diabetes are currently in Phase II trials.
User avatar
Leonard
Family Elder
Posts: 1090
Joined: Fri Dec 18, 2009 3:00 pm
Location: Brussels

Re: Geneuro

Post by Leonard »

watoo75 wrote:
Biotech Showcase™: GeNeuro homes in on ancestral viral genes to treat autoimmune diseases

Focusing on an idea that many autoimmune diseases are caused by proteins from viral genes that are now embedded in human DNA, Swiss biotech GeNeuro is using the approach to tackle diseases such as multiple sclerosis and type 1 diabetes. Indeed, 8% of the human genome comes from genes left there by infections that affected our ancestors. Speaking at the 2018 Biotech Showcase, GeNeuro co-founder and CEO Jesús Martin-Garcia explained to Scrip how the company is advancing therapeutic candidates designed to neutralize the causal factors encoded by human endogenous retroviruses that lead to autoimmune diseases. The company’s lead programs focusing multiple sclerosis, and partnered with Servier, and type 1 diabetes are currently in Phase II trials.

is it ancestral viral genes or is it more recent (40 - 100 M years old) EBV?

it would seem that EBV B cells are causal; they react with common epitopes on EBV infected cells when they come to expression.
this causes oxidative stress, successive mitochondrial failure, degeneration etc.

perhaps some epitopes from HERV have common characteristics with EBV.
in that case, old viral remains may add to our problem.
User avatar
watoo75
Newbie
Posts: 6
Joined: Sun Jun 03, 2007 2:00 pm
Location: PARIS
Contact:

Re: Geneuro

Post by watoo75 »

Sure that gmbac1 is the solution
User avatar
watoo75
Newbie
Posts: 6
Joined: Sun Jun 03, 2007 2:00 pm
Location: PARIS
Contact:

Re: Geneuro

Post by watoo75 »

Gnbac1 is the key.
Post Reply

Return to “General Discussion”